Mesoblast Investor

Mesoblast is a medicine company that develops biologic products for the broad field of regenerative medicine.

Last Funding Type: Post-IPO Equity
Funding Status: IPO
Headquarters: Australia
Founded Date: 2004-01-01
Investor Type: N/A
Investment Stage: N/A
Last Funding Date: 2020-05-13
Total Funding: 227295275 USD
Technology: diagnostics
Employee Number: 51-100
Number Of Exists: 1
Estimated Revenue: $10M to $50M
Investors Number: 2
Industry: Biotechnology, Health Care, Science and Engineering